CSI Market
Sign In | Register

Bio techne (TECH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TECH Annual Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Bio techne's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
12 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income181.84
Depreciation & amortization97.36
Amortization of Other Assets61.79
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories8.23
R & D, Environmental and Other Expense0.00
Business Combination Step Acquisition Equity InterestIn Acquiree Remeasurement Gain0.00
Share-based Compensation41.37
Proceeds from Equity Method Investment, Dividends or Distributions0.89
Financial Instruments and Foreign Currency Transaction0.00
Fair Value Adjustment To Contingent Consideration Payable-
Fair Value Adjustment On Available For Sale Securities-
Noncash Portion Of Lease Expense-2.62
Asset Impairment Restructuring Charge3.25
Fair Value Write Up Of Acquired Inventory-
Income taxes0.00
Losses/ -gains on Investments net-5.86
Accounts Receivable3.12
Increase (Decrease) in Accounts Payable and Accrued Liabilities3.18
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-5.26
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-94.57
Discontinued operations0.00
Net Cash flow from Operating Activities292.07
Investing Activities
Capital Expenditures-28.85
Sale of Capital Items4.62
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Payments for Derivative Instrument, Investing Activities0.00
Proceeds From Return Of Capital From Interest In Affiliates-
Investment In Unconsolidated Entity-
Proceeds From Sale Of Equity Securities Fv Ni-
Payments To Acquire Equity Securities Fv Ni-
Proceeds Payments From Equity Method Investment Dividends Or Distributions Return Of Capital-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital6.04
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-18.19
Financing Activities
Short-term debt Net-146.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock38.94
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-12.14
Other net0.00
Purchase Of Common Stock For Stock Bonus Plans-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-49.92
Net Cash Flow from Financing Activities-169.11
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow267.84
Total Cash Flow102.53
4 historic quarters locked

Sign in to unlock the full Bio techne cash flow history.

Sign In Create Free Account

About Bio Techne Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-056302

Figures are derived from filed reports and may be restated. Historical data is subject to revision.